Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacogenomics of weight loss with sibutramine in obese and overweight patients

Trial Profile

Pharmacogenomics of weight loss with sibutramine in obese and overweight patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2008

At a glance

  • Drugs Sibutramine (Primary)
  • Indications Obesity
  • Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 26 Dec 2007 Status changed from recruiting to completed.
    • 09 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top